Haematologica, Vol 93, Issue 3, 467-468 doi:10.3324/haematol.11988
Copyright © 2008 by Ferrata Storti Foundation
Stephanie Struski1, ,
Laurent Mauvieux1 ,
Carine Gervais1 ,
Catherine Hélias1 ,
Kun Lun Liu2 ,
Michel Lessard1
A semi-nested RT-PCR was realized, using exon 2 ETV6 forward primers (5'-ACACCTCCAGAGAGCCCAGT-3' and 5'-TCAGGATGGAGGAAGACTCGA-3', NM_001987) in combination with an exon 3 GOT1 reverse primer (5’-CACATAGACAGGTGTGTTCTTGT-3’, NM_002079). The result of the amplification is shown in Figure 1B. Two strong bands were obtained in the patient sample, contrasting with the unspecific amplification detected in the REC cell line. Sequence analysis of the smaller PCR product showed a transcript encoding an in-frame fusion between ETV6 exon 3 and GOT1 exon 2 (in the previous published case, ETV6 exon 2 was fused to GOT1 exon 2)(sequence references Ensembl7). The larger band was composed of the same ETV6 sequences fused to genomic sequences of chromosome 10 due to a cryptic splice acceptor site. The location of this site was 22 kb telomeric to GOT1 and 79 kb centromeric to NKX2-3 (Figure 2). This 10q24 breakpoint, very close to that of the already published case, was located within the hmm50206 putative transcript, predicted by Gnomon algorithm gene prediction analysis on genomic contig NT_030059.12. The corresponding chimeric protein stopped after 11 aminoacids due to a stop codon in the coding sequence. We also verified the reciprocal transcript using exon 4 ETV6 primer (5'-CGAGGTTTCCTCTGCTTCAG-3') and exon 1 GOT1 primer (5'-ATATGGCACCTCCGTCAGTC-3'). As expected, RT-PCR did not detect the reciprocal GOT1-ETV6. Although the del(5q) was the first abnormality, we can hypothesize that the appearance of t(10;12) in a sub-clone had an accelerator effect on the MDS. During the AML phase, the t(10;12) was observed in all metaphases, the others abnormalities attesting to the acceleration. The chimeric ETV6-GOT1 predicted protein is composed of a N-terminal part of ETV6 containing the SAM domain, inducing oligomerization, and the quasi totality of GOT1. Only a short N-terminal part of GOT1 is lacking, necessary for enzymatic activity as described in the only previous case published.6 The resulting protein can still form homo- or heterodimers that may act as a dominant negative form for GOT1 but also for ETV6. The SAM domain of ETV6 may result in the inactivation of the protein, and so contribute to leukemogenesis as suggested in acute myeloid leukemia.8 Another consequence of this translocation might be the transcriptional deregulation of the homeobox gene NKX2-3, which lies adjacent to the breakpoint. The case reported here confirms the presence of a chromosomal breakage hot spot in chromosome 10 and the recurrence of the t(10;12)(q24;p13) in MDS-related AML. Attention should be paid to identify this abnormality in such cases in order to evaluate its frequency and its clinical implications.
Copyright © 2008 by Ferrata Storti Foundation
Letters to the Editor |
ETV6/GOT1 fusion in a case of t(10;12)(q24;p13)-positive myelodysplastic syndrome
1 Laboratoire d’Hématologie, Hôpital de Hautepierre, Avenue Molière, Strasbourg
2 Département d’Hématologie et d’Oncologie, Hôpital de Hautepierre, Strasbourg, France
Correspondence: Stephanie Struski, Laboratoire d’Hématologie, Hôpital de Hautepierre, avenue Molière, 67000 Strasbourg, France. Fax: international +33.3.88125575. E-mail: stephanie.struski{at}chru-strasbourg.fr
ABSTRACT
The ETV6/GOT1 fusion, resulting from t(10;12) (q24;p13), has been recently described in a myelodysplastic syndrome. We reported a second case of t(10;12)-positive myelodysplastic syndrome in whom fluorescent in situ hybridization confirmed the non-random translocation but molecular biology analyses revealed a ETV6/GOT1 chimera varying from the first case described.
Key words: ETV6, GOT1, myelodysplastic syndrome.
ETV6 (ets variant gene 6) is frequently rearranged in both myeloid and lymphoid hematologic malignancies and to date, 24 translocation partner genes with fusion transcripts have been identified.1–5 These partners are heterogeneous and include kinases as well as transcription factors. Janssen et al.6 recently reported a t(10;12)(q24;p13) in MDS leading to an ETV6-GOT1 fusion. GOT1, glutaminic-oxaloacetic transaminase 1, encoding for a cytosolic enzyme, is involved in amino acid metabolism and in the urea and tricarboxylic acid cycles (Genbank Accession number NM_002079). The consequences of the ETV6-GOT1 fusion have not yet been established.
We present here a second case of t(10;12)(q24;p13) suggesting a recurrent translocation in MDS, with a breakage hot spot on chromosome 10.
A 71 year old woman with chronic macrocytosis was admitted for pancytopenia. Blood analysis showed the following: hemoglobin 89 g/L, platelets 157x109/L and white blood cell count 1.3x109/L with 52% neutrophils, 45% lymphocytes, 3% monocytes, no circulating blasts. The bone marrow showed 10% blasts establishing the diagnosis of refractory anemia with excess blasts (RAEB). Five months later, she was admitted with a fever. A bone marrow evaluation confirmed the transformation to an acute myeloid leukemia (AML) M1 according to the FAB classification. The patient died five days later.
At diagnosis, karyotype revealed 46,XX,del(5)(q13q34) [11]/46,idem,t(10;12)(q24;p13)[5]/46,XX[6]. The cytogenetic analysis at transformation displayed:46,XX,der (2)t(2;11)(q34;q14~21),del(5)(q13q34),idic(8)(p12),t(10;12) (q24;p13)[22].
As this case was very similar to the one previously described,6 we tested the hypothesis of a fusion involving ETV6 and GOT1 genes. Hybridization with the ETV6/AML1 probe (Abbott), which covers the SAM domain of ETV6, and BAC RP11-441O15 (RZPD, Berlin, Germany) for the GOT1 locus, confirmed fusion signals of ETV6 and GOT1 on both derivative chromosomes 12 and 10 (Figure 1A).
 View larger version (38K): [in a new window] [Download PPT slide] |
Figure 1. Characterization of the ETV6-GOT1 fusion: (A) Partial RHG bands showed a t(10;12)(q24;p13). Hybridization of ETV6 probe in green and RP11-441O15 (GOT1) in red showed two fusion signals on both derivative chromosomes. (B) cDNA obtained from cytogenetic pellet was amplified using primers located in exon 2 of ETV6 and exon 3 of GOT1. A semi-nested RT-PCR was performed in order to increase the specificity and the amplification of low expressed transcripts. The smaller band (S) corresponded to the ETV6-GOT1 fusion transcript. Sequence analysis of the larger band (L) identified a chimeric transcript containing ETV6 sequence fused to genomic sequences located at 22961 bp 3’ to GOT1 and 79407 bp 5' to NK2 transcription factor related, locus 3 (NKX2-3).
|
 View larger version (19K): [in a new window] [Download PPT slide] |
Figure 2. Schematic representation of 10q24 and 12p13 regions implicated in the t(10;12) and transcripts identified. (A) Genomic representation of t(10;12). Only exons of known genes are indicated in boxes. Orientation of the genes are indicated by arrows and breakpoint by dotted line. The Sterile Alpha Motif (SAM) domain (exons 2 to 4), responsible for hetero- and homodimerization with other ETV6 proteins and possibly other ETS family members, is indicated. (B) Transcripts identified. ETV6 sequences are in bold and underlined, and stop codon is boxed. No reciprocal transcript was identified.
|
Acknowledgments
we thank Dr. Alice Eischen, Pr. Raoul Herbrecht, Cathy Gangneux and Nathalie Perrusson whose excellent work could not be included because of limited space
References
- Bohlander SK. ETV6: a versatile player in leukemogenesis. Semin Cancer Biol 2005;15:162-74.[CrossRef][Web of Science][Medline]
- Curtis CE, Grand FH, Musto P, Clark A, Murphy J, Perla G, et al. Two novel imatinib-responsive PDGFRA fusion genes in chronic eosinophilic leukaemia. Br J Haematol 2007;138:77-81.[CrossRef][Medline]
- Hosoya N, Qiao Y, Hangaishi A, Wang L, Nannya Y, Sanada M, et al. Identification of a SRC-like tyrosine kinase gene, FRK, fused with ETV6 in a patient with acute myelogenous leukemia carrying a t(6;12)(q21;p13) translocation. Genes Chromosomes Cancer 2005;42:269-79.[CrossRef][Medline]
- Lu XY, Harris CP, Cooley L, Margolin J, Steuber PC, Sheldon M, et al. The utility of spectral karyotyping in the cytogenetic analysis of newly diagnosed pediatric acute lymphoblastic leukemia. Leukemia 2002;16:2222-7.[CrossRef][Medline]
- Panagopoulos I, Strombeck B, Isaksson M, Heldrup J, Olofsson T, Johansson B. Fusion of ETV6 with an intronic sequence of the BAZ2A gene in a paediatric pre-B acute lymphoblastic leukaemia with a cryptic chromosome 12 rearrangement. Br J Haematol 2006;133:270-5.[CrossRef][Medline]
- Janssen H, Wlodarska I, Mecucci C, Hagemeijer A, Vandenberghe P, Marynen P, et al. Fusion of ETV6 to GOT1 in a case with myelodysplastic syndrome and t(10;12)(q24;p13). Haematologica 2006;91:949-51.
[Abstract/Free Full Text] - Hubbard TJ, Aken BL, Beal K, Ballester B, Caccamo M, Chen Y, et al. Ensembl 2007. Nucleic Acids Res 2007;35:D610-7.
[Abstract/Free Full Text] - Barjesteh van Waalwijk van Doorn-Khosrovani S, Spensberger D, de Knegt Y, Tang M, Lowenberg B, Delwel R. Somatic heterozygous mutations in ETV6 (TEL) and frequent absence of ETV6 protein in acute myeloid leukemia. Oncogene 2005;24:4129-37.[Web of Science][Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||